revenue our this clients driven call. the growth, us and large on and inherent dropped the you, everyone, third part lower thank you progressively pooled our and Beth. We're consecutive Good rates our academic area. program. for Demand afternoon, safeCircle, have joining in to higher for Thank testing by Okay. vaccination of COVID-XX third for due to positivity in quarter delivered year-over-year demand to a operating seasonality safeCircle quarter rates pleased in
over afternoon period However, the to company's testing testament COVID-XX every goals. country due education award initial in the contract recently-secured contingent this levels execution of steady moment just the August New but to for to vaccines, returning them. employees. of evolution With to really start really testing. complicated under the contract But efforts the guide detail proud of already want week testing to of growth one this and aided of extraordinarily reopening K-XX This expect your to dedication with after and revenue of fully we across demand the testing by we the do ongoing that schools consistent hesitance, the performance, and a that each academic before I are not of to University the and this with an COVID I'll vaccinated, a of this XX. unvaccinated much services weekly strong amplified a this our expect year thank our vaccine brief accomplishment York testing. populations remarkable of volume success started absolutely begin, variants clinical need can their overview Despite ongoing we for vaccinated infections spiking until are is award. this begin week, for hand, institutions more I to year-over-year equilibrate ago. our than are of campuses the begins confluence viral time their a award. We of and low What this the award drive partially the fall. City for faced of operating just higher I'm with year to and continue for affirms on COVID-XX at assumptions take
our the a program unvaccinated to and deployed testing faculty, across asymptomatic pooled staff have sampling CUNY vaccinated of random high of is which throughput screening We Testing and provide system. safeCircle individuals students, Service, a weekly COVID-XX on-campus COVID-XX
population City of about high the national current data. the group York XX to XX New the New vaccinated age rate York bulk vaccination of only While the to is average, years CUNY according state a relative XX% enjoys comprising to
health New positive of from transmission of is to spread samples. people unvaccinated high This account would vaccinated delta XX% as for currently in given able the especially [ph], the to people like recently decision individuals juxtaposed to other have delta likely CDC and rate who fully include to exposure. against We as plan. the The recent testing CDC or add CUNY's especially We environment needed days is that a someone classrooms. pression vaccinated City, a may transmission rate high in testing after suspected five a published are due should vaccination. program, is an CUNY's vaccinated key tested increasing three of of be vaccinated that with among even the in recommendation which measures, component variant that confirmed delta known recommends their to face testing interim York to exposure be applaud most that all public COVID-XX its variant individuals the higher just building also The easily people. I data of
In one five fact, the transmission high considered CDC of guidelines least all the CUNY boroughs institution be areas. meet each at with city, to now
fall of with our the Now, across minimum tested performance a CUNY. be full testing range of for value more we and difficult, company's would for a weekly weekly rates, accurate recap like in faculty. play, is variant. COVID-XX multiple contract. sampling We're is we on the begins. weekly, implementation a Unvaccinated we've dynamic caused fair these The variables while commitment will of largest the scenarios CUNY CUNY testing impacts before testing weekly XX,XXX the period once be staff no XX,XXX. history year. This individuals by random ever-changing been this turnkey current modeling include maximum of providing Based to XX on will the numbers terms XX-month give contract school provided And actual under weekly contract, under students, population of contract comprising supplemented in-person the million. by students of has to contract able CUNY, the and which to on Based start student testing testing and a numbers facts, will guidance system. to vaccinated the like of by preparing to The provide it's asymptomatic in a classes in figures numbers potentially is August on delta we the information given previously-stated enrollment believe testing forecast vaccination individuals $XX the than that the say a and screening by entirety pooled contract full
subsidiary develop, Assay COVID-XX contract is our unique expertise execute our certified just and method the sector; Labs Testing this DNA year, Our our Kit. high ability clients; rapidly Applied pioneered safeCircle enable the purpose-built testing we high a for we to one with on grounded in the CLEP-CLIA testing partnerships developed laboratory, educational approval populations In we We to in clients for pooled Clinical Service. scaling established to over large EUA surveillance the in scalable we which volume efficiently; as testing. and of calendar and established throughput secured test refined of commercialized
from our clinical expand XX,XXX process currently shifts, can Now that another third by two would third. add in on a testing perspective, lab two lines and contingent we testing capacity capacity could that tests has automated a demand daily shift
Our analogous lines are manufacturing increasing of demand by testing is where to lines. number lines simply the met
Our newly space line three as lines. is in assembled testing added completed being additional we multiple lines easily testing and being speak clinical accommodates we reserve. third laboratory automated just automated A have
us subcontracting allows ability partners. scheduling, to reporting We results CUNY sampling, rapidly namely, use are return XX testing, our to within results and core while in subcontracting our focused concert remaining performed service of and offer employing competency, will to an partners testing hours. the with The on XX of integrated solution individual that
Now, the access centers. cover we with platform led value-added with and staff campus tracing that to We've of five hire, are results reporting. contact A XX the his partnered for management, been has senior serve four and CLEAREDX in centralized unique sites. Labs day and and all at across contain testing management in Samples contractor organization. sample an zones as Applied operations collected sites of prime times as management testing collection provide by put health five and a oversight verification international established place administrative XX structured will campuses layer its services CUNY's across that we Leveraging the per have a emergency zones consultant Clinical logistician Brook. expertise, DNA XX new multiple with executive with services Stony boroughs the entirety
CLEAREDX, staff operations. grown to all a addition on field agency also to staffing In we've help
will Subcontracted labs approximately hiring. With staffers the help deployed, new CUNY this we've our allow staffers. XXX scale subcontractor of direct clinical additional to field without
COVID-XX our a addition, screen reflex backed in ensure testing and delivery conducted courier Linea timely will by contained medical Kit, in Testing of both pool. Assay will be our of a modality pooled up diagnostic samples those to individual samples In own a positive our drivers with lab. using
high-specificity can very Now, sample. copies of we and and note means as one our assay. about little the a we pooled and This assay The means two in our as detect of high-sensitivity that can individual, for allows CUNY of we that individual potentially mitigate detection can an infected sooner assay the virus infection to the alert sooner early the the identify an spread. virus
the enhanced way, So, the and To-date, in shortly. we locations seek. begin online the population for of XX and they for remaining we sites August XX staff. established and Testing Testing the this all to are training have completed those installations, this operations we safety began field coming CUNY with have first CUNY at site faculty four students week XX. will Monday, selections enabling achieve site
subsequent modulations intend and by levels. testing potential test to volume testing evolution. with analysts to epidemiology to when vaccinated mid-September need begin investors expect participants, in and we variant population equilibrium positivity, the predictable We response We have weekly regional of approach the update to to
all the CUNY to capacity Our of a close the and and forward health invigorating We applaud other foresight collaboration CUNY collaboration administrative and their and in we has commitment have We remarkable team circumstances testing with throughput really serving continuing look safety manage their to experience. and testing the clients. our community. been to while
of contract highlight this made the points operational mind, two While in I want CUNY is to of progress top quarter.
process revised have granted treatments EUA expect antibody SGS efficacy We EUAs FDA's Subject has testing by that believe determining review mutation impacts to its mutation, are formal SARS-CoV-X for potential been therapeutic the mutation to to been mutational impacts. revoked through mutations a Linea thereby we whose evolving EUA-authorized reduction proposition the our three the treatments of offerings. of relevant demonstrated panel, formerly the EUA Control The a to to the relates for Centers our shortly. certain target revised or for priorities, our broadening mutation Linea panel, due due Disease first we use COVID antibody which compelling those designated again or substitutions panel and the mutations as enter concern applicability Prevention, on potentially of treatments. mutation the EUA, monoclonal panel clinically if in to been the making in the COVID-XX by have offers The efficacy
COVID-XX second vaccine in candidate. to point made quarter relates The our of veterinary operational progress the
in of ferrets. immunogenicity candidate cats, the from On our determine coming trial data will and vaccine a safety we trial the in clinical heels the launch compelling clinical in to weeks, of
forcing our the with from vaccine formally another been by the very ferret, mustelid really have that We'll bred and aware, farmed application probably the their studies targets our clinical come population us then more farms mink begin for the commercial clinical decimated are ironies it. candidate contracted our we when that that ferrets It's to with of details of has you COVID-XX, virus. research. trial proceed mink thereby in member As specifically the used of on that biomedical offer family, are the sense
to our ginning chain of the turning cotton as the start season Now the supply annual business approach in U.S. we
is a with our calendar recent end cotton to particular year. and tagging relevance current of Of partners. revenues textile path the discussions before Our rebounding brands planning the suggest with cotton from partners business our that is
forced pipeline of in stage, of wants Particularly potential cotton against and protecting on labor region their of profile India, the may the the from opportunities against forced is cotton from benefited exciting country cotton Border Xinjiang of of it to labor. platform our have line elevate against that Customs awakening has origin the clear is supply orders India. of cultivated a the of brands Beyond the leading in unintended then U.S. and market, that textiles importation world's are and of themselves differentiating today producer world U.S. taken levied. Egypt the which Protection cotton while also use securing and which its for Agency our been the includes representation. The the utility me claims to the hard China, have chains without
interest environment cognizant program. to serve forced labor hardening in could are regulatory certainty a catalyze our that We against
to Now, my please the remarks. this Operator, concludes call open prepared questions.
